- Sept 8, 2021: Biomarkers
- Sept 22, 2021: Neuroscience and Epidemiology of Drug Addiction
- Oct 6, 2021: Genetics
- Oct 20, 2021: Zebrafish - Development
- Nov 10, 2021: Sensor & Apps for Health Monitoring
- Dec 8, 2021: Development of Chemotherapeutics
- Jan 5, 2022: Kentucky Commercialization Ventures
- Jan 19, 2022: Neurotoxicity & Brain Health
- Feb 9, 2022: Bacteria and Enzymes
- Feb 23, 2022: Biotechnology
- March 9, 2022: Psychology & Language
- March 23, 2022: Genomics and Electron Microscopy Cores
- April 6, 2022: R16 Funding Mechanism
Sept 22, 2021: Neuroscience and Epidemiology of Drug Addiction
-
4 pm: Justin Yates, Northern Kentucky University Psychological Sciences, Contribution of NMDA NR2B subunit to risky choice and economic demand for Cocaine
-
4:15 pm: Mark Bardgett, Northern Kentucky University Psychological Sciences, Long-term effects early-life antipsychotic drug treatment
-
4:30 pm: Brad Kraemer, Eastern Kentucky University Biological Sciences, Effects of p75NTR on Oxidative Stress-Induced Degeneration of NMS Neurons
-
4:45 pm: Bikram Subedi, Murray State University Chemistry, Determination of the prevalence of controlled neuropsychiatric drugs using waste-water epidemiology and its potential correlation with the conventional survey-based estimation
- Sept 8, 2021: Biomarkers
- Sept 22, 2021: Neuroscience and Epidemiology of Drug Addiction
- Oct 6, 2021: Genetics
- Oct 20, 2021: Zebrafish - Development
- Nov 10, 2021: Sensor & Apps for Health Monitoring
- Dec 8, 2021: Development of Chemotherapeutics
- Jan 5, 2022: Kentucky Commercialization Ventures
- Jan 19, 2022: Neurotoxicity & Brain Health
- Feb 9, 2022: Bacteria and Enzymes
- Feb 23, 2022: Biotechnology
- March 9, 2022: Psychology & Language
- March 23, 2022: Genomics and Electron Microscopy Cores
- April 6, 2022: R16 Funding Mechanism